Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |